Fosamax Femur Plaintiffs Urge Supreme Court To Deny Preemption Review

Mealey's (October 31, 2017, 11:36 AM EDT) -- WASHINGTON, D.C. — Counsel for more than 500 Fosamax femur fracture plaintiffs on Oct. 25 urged the U.S. Supreme Court to deny certiorari to Merck Sharp & Dohme Corp., arguing that...
To view the full article, register now.